Clinical Trial
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies
- PMID: 225026
Item in Clipboard
Clinical Trial
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies
Cancer Treat Rep.
1979 Aug.
No abstract available
Similar articles
-
Etoposide (VP-16-213). Current status of an active anticancer drug.N Engl J Med. 1985 Mar 14;312(11):692-700. doi: 10.1056/NEJM198503143121106. N Engl J Med. 1985. PMID: 2983208 Review. No abstract available.
-
Treatment strategies in relation to drug action.NCI Monogr. 1987;(4):129-33. NCI Monogr. 1987. PMID: 2819724 No abstract available.
-
[New antineoplastic drugs of the podophyllotoxin derivative group].Pol Tyg Lek. 1983 Jan 3;38(1):27-30. Pol Tyg Lek. 1983. PMID: 6346283 Clinical Trial. Polish. No abstract available.
-
[Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 1):496-501. Gan To Kagaku Ryoho. 1986. PMID: 3954373 Japanese.
-
Review of etoposide.Clin Pharm. 1983 Mar-Apr;2(2):112-9. Clin Pharm. 1983. PMID: 6309469 Review. No abstract available.
Cited by
-
Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.Cancer Chemother Pharmacol. 1995;36(2):172-5. doi: 10.1007/BF00689204. Cancer Chemother Pharmacol. 1995. PMID: 7539339
-
Therapeutic drug monitoring in 21-day oral etoposide treatment for lung cancer.Jpn J Cancer Res. 1996 Aug;87(8):856-61. doi: 10.1111/j.1349-7006.1996.tb02111.x. Jpn J Cancer Res. 1996. PMID: 8797893 Free PMC article.
-
Schedule-dependent topoisomerase II-inhibiting drugs.Cancer Chemother Pharmacol. 1994;34 Suppl:S84-8. doi: 10.1007/BF00684869. Cancer Chemother Pharmacol. 1994. PMID: 8070033 Review.
-
A phase I trial of continuous infusion VP16-213 (etoposide).Cancer Chemother Pharmacol. 1982;7(2-3):157-60. doi: 10.1007/BF00254539. Cancer Chemother Pharmacol. 1982. PMID: 7083457
-
Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer.Jpn J Cancer Res. 1996 Feb;87(2):200-5. doi: 10.1111/j.1349-7006.1996.tb03159.x. Jpn J Cancer Res. 1996. PMID: 8609070 Free PMC article. Clinical Trial.